Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[S,S]-Reboxetine in Postherpetic Neuralgia (PHN)
NCT00143442Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2003
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing [S,S]-Reboxetine with Placebo (2 arms). Primary endpoint: Numerical Pain Intensity Rating Scale Score at 5 weeks. Started Dec 2003; status: completed.
02
Drugs
esreboxetine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00143442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00143442.